On February 20, 2024, Processa Pharmaceuticals, Inc. CEO George Ng presented at the Winter Wrap-Up MicroCap Rodeo Conference. The company, listed on the Nasdaq Capital Market under the trading symbol PCSA, is based in Hanover, Maryland, and is incorporated in Delaware. Processa has provided the presentation materials as Exhibit 99.1, which are also accessible to investors on the company's website. While Processa has no obligation to update the information presented, it may do so in the future through various public disclosure methods. The information disclosed in the presentation and the report is not considered filed under the Securities and Exchange Act of 1934 and is not subject to its liabilities, nor is it incorporated by reference into any filings under the Securities Act of 1933, unless specifically referenced.

On February 20, 2024, Processa Pharmaceuticals, Inc. CEO George Ng presented at the Winter Wrap-Up MicroCap Rodeo Conference. The company, listed on the Nasdaq Capital Market under the trading symbol PCSA, is based in Hanover, Maryland, and is incorporated in Delaware. Processa has provided the presentation materials as Exhibit 99.1, which are also accessible to investors on the company's website. While Processa has no obligation to update the information presented, it may do so in the future through various public disclosure methods. The information disclosed in the presentation and the report is not considered filed under the Securities and Exchange Act of 1934 and is not subject to its liabilities, nor is it incorporated by reference into any filings under the Securities Act of 1933, unless specifically referenced.